NCT05166343View on ClinicalTrials.gov

POHCA Resuscitation: Evaluation of IM Epinephrine

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2029

Conditions
Pediatric Out-of-Hospital Cardiac Arrest
Interventions
DRUG

Epinephrine Injection

Epinephrine administered via sterile epinephrine injection USP, by 0.3mg or 0.5mg epinephrine auto-injector(s) and/or pre-filled syringe (exact dose).

Trial Locations (1)

N6A 5W9

RECRUITING

Children's Hospital - London Health Sciences Centre, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER